RVMD
Revolution Medicines, Inc.
Stock
$205.26+0.78 (+0.38%)Close Sep 30, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $3.9B | $2.0B | $2.3B | $1.9B | $645M | $577M | $441M | $123M | $70M |
| Current assets | $4.0B | $2.1B | $2.3B | $1.9B | $660M | $590M | $454M | $134M | — |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | — |
| Intangible assets | $56M | $56M | $57M | $58M | $59M | $60M | $61M | $62M | — |
| Total assets | $4.3B | $2.4B | $2.6B | $2.1B | $812M | $738M | $567M | $221M | — |
| Current liabilities | $354M | $290M | $164M | $144M | $62M | $60M | $47M | $43M | — |
| Total liabilities | $1.7B | $723M | $293M | $236M | $127M | $135M | $93M | $68M | — |
| Shareholders' equity | $2.6B | $1.6B | $2.3B | $1.8B | $685M | $603M | $475M | −$153M | −$108M |
| Shares outstanding | 214.3M | 198.2M | 185.9M | 164.7M | 90.5M | 74.2M | 73.4M | — | — |
| Current ratio | 11.38 | 7.14 | 14.20 | 13.06 | 10.65 | 9.77 | 9.63 | 3.11 | — |